A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around ...

For many patients on tirzepatide, a transformative medication used for weight loss and diabetes, the end of the drug's ...

Pivotal Peptides says it offers research-grade tirzepatide ... from selling their versions of Eli Lilly's blockbuster weight loss and diabetes drugs. The agency said in a court filing it would ...

Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed a "shocking first miss" during its most recent ...

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

Pharmacies currently making copycat versions of Eli Lilly’s tirzepatide face heightened exposure to state enforcement actions ...

The drugmaker has received approval from the Hong Kong government to sell its tirzepatide injections — branded as Mounjaro — ...

It also said it would not take enforcement action — for now — against pharmacies making their own versions of weight-loss drugs based on Eli Lilly’s tirzepatide, according to a letter it ...

All the evidence gathered from the five-year trial will be used to demonstrate the long-term effect of weight loss medication ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...